Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure.

<h4>Background</h4>There is insufficient evidence whether the benefit of adding angiotensin II receptor blockers (ARBs) to angiotensin-converting enzyme (ACE) inhibitors outweighs the increased risk of adverse effects in patients with heart failure.<h4>Methodology/principal finding...

Full description

Bibliographic Details
Main Authors: Andrea Kuenzli, Heiner C Bucher, Inder Anand, Gregory Arutiunov, Leo C Kum, Robert McKelvie, Rizwan Afzal, Michel White, Alain J Nordmann
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-04-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20376345/?tool=EBI